Phase-appropriate bioanalysis for monoclonal antibody programs aligned with global regulatory expectations

Partner with a CRO that combines scientific expertise with regulatory insight to deliver bioanalytical strategies tailored to your drug development goals


Celerion scientist working at lab bench

Full-service bioanalysis in one location


Celerion’s GLP, GCP, CAP, and CLIA compliant laboratories provide assay development, validation and sample testing for preclinical and clinical monoclonal antibody programs including:

  • Pharmacokinetics
  • Immunogenicity
  • Biomarkers

Simplify your outsourcing by leveraging the breadth of our expert bioanalytical services.

Robust bioanalytical methods built on our monoclonal antibody experience


At Celerion, we take a collaborative approach, building upon our more than 5 decades of expertise to provide you with fit-for-purpose solutions for your monoclonal antibody program. This can mean including sample pretreatments to boost drug tolerance of immunogenicity methods, taking a simplified approach to immunogenicity testing with fewer assay tiers, or developing an assay strategy to include both free and total PK measurements. Our past successes with methods to support monoclonal therapeutics translate into quicker development times and faster results for you.

Celerion scientist using a multichannel pipette to load an assay plate

Ready to Get Started?

Contact us today to discuss how our flexible, scientifically driven approaches can provide you with top-tier bioanalytical solutions.

Contact Us